Codiak BioSciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Codiak BioSciences, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $13.00 thousand as of 2022-06-30, per its 10-Q filed 2022-08-04.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2022-11-03
- 2022-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $13.00K.
- 2022-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $3.36M.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $10.37M.
- 2021-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $27.89M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value |
|---|---|
| 2022-06-30 | $13.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $3.36M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $10.37M 10-Q · filed 2022-11-03 |
| 2021-09-30 | $27.89M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $41.55M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $29.11M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $108.05M 10-K · filed 2022-03-10 |
| 2020-09-30 | $29.95M 10-Q · filed 2020-11-19 |
| 2019-12-31 | $10.52M 10-K · filed 2021-03-17 |